Steroid Injection for the Treatment of Greater Trochanteric Pain Syndrome

Withdrawn before enrolling · Phase 4

Conditions studied: Bursitis

In brief

The objective of this study is to conduct a randomized, single-blinded placebo controlled trial comparing two modalities for the treatment of pain and mobility associated with trochanteric bursitis: (1) injection of glucocorticosteroid and local anesthetic, (2) injection of local anesthetic. We hope to determine whether steroid injections provide a statistically significant improvement in pain symptoms and hip mobility in subjects with trochanteric bursitis, as compared to an injection of local anesthetic. Our null hypothesis is that no statistically significant difference exists between the two treatment modalities.

Key facts

Study ID

NCT00863889

Run by

Emory University

People needed

0

Starts

2009-03-01

Expected to finish

2010-02-01

Last updated by the study team

2013-09-23

Who can join

Age: 17 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients with tenderness at the greater trochanter

You may not qualify if…

• Subjects < 17 years of age
• Subjects with previous surgery to the greater trochanter
• Subjects allergic to Lidocaine, Marcaine, or Depomedrol

Where it is running

• Dr. Tom Bradbury — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.